Skip to main content
Frontiers in Oncology logoLink to Frontiers in Oncology
. 2020 Nov 3;10:582704. doi: 10.3389/fonc.2020.582704

Corrigendum: Cyclooxygenase-2 and β-Catenin as Potential Diagnostic and Prognostic Markers in Endometrial Cancer

Lin Deng 1,2,*, Haiyan Liang 1,*, Yi Han 3
PMCID: PMC7670668  PMID: 33224882

In the original article, there was a mistake in the Supplementary Table named Table S3 AUCs, Sensitivity, Specificity of cox2, β-catenin and wnt3a in predicting diagnosis, myometrial invasion, vessel invasion, lymph node metastasis, and poor prognosis as published. The specificity of wnt3a in serum for myometrial invasion is 0.316 and the p value is 0.010. The corrected Supplementary Table S3 appears below.

Table S3.

AUCs, Sensitivity, Specificity of cox2, β-catenin and wnt3a in predicting diagnosis, myometrial invasion, vessel invasion, lymph node metastasis, and poor prognosis.

Item AUCs Sensitivity Specificity 95% CI P
Diagnosis Cox2 expression 0.931 0.918 0.812 0.882–0.981 0
β-catenin expression 0.933 0.902 0.750 0.886–0.980 0
Cox2 in serum 0.887 0.951 0.719 0.805–0.968 0
Wnt3a in serum 0.931 0.967 0.812 0.873–0.981 0
Myometrial invasion Cox2 expression 0.732 0.826 0.500 0.605–0.860 0.003
β-catenin expression 0.692 0.783 0.526 0.556–0.6827 0.013
Cox2 in serum 0.590 0.913 0.237 0.437–0.744 0.240
Wnt3a in serum 0.698 0.913 0.316 0.566–0.830 0.010
Vessel invasion Cox2 expression 0.702 0.739 0.632 0.567–0.837 0.009
β-catenin expression 0.763 0.783 0.526 0.619–0.906 0.001
Cox2 in serum 0.696 0.739 0.632 0.558–0.834 0.011
Wnt3a in serum 0.757 0.783 0.632 0.631–0.884 0.001
Lymph node metastasis Cox2 expression 0.692 0.800 0.549 0.537–0.847 0.056
β-catenin expression 0.693 0.700 0.686 0.522–0.864 0.055
Cox2 in serum 0.732 0.800 0.627 0.596–0.869 0.021
Wnt3a in serum 0.711 0.700 0.765 0.517–0.905 0.036
Prognosis Cox2 expression 0.789 0.850 0.659 0.676–0.902 0
β-catenin expression 0.869 0.850 0.854 0.767–0.971 0
Cox2 in serum 0.752 0.800 0.732 0.623–0.881 0.002
Wnt3a in serum 0.711 0.750 0.585 0.561–0.861 0.008

An author was incorrectly labeled as Haiyan Liang1, as she is the co-correspondence author. The correct label is Haiyan Liang1*.

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.


Articles from Frontiers in Oncology are provided here courtesy of Frontiers Media SA

RESOURCES